In a landmark development for India’s traditional medicine sector, the Ministry of Ayush has entered into a formal partnership with the World Health Organisation (WHO) to integrate Ayush practices into the global healthcare system...
The National Accreditation Board for Testing and Calibration Laboratories (NABL) is encouraging its accredited Conformity Assessment Bodies
Divi's Laboratories Limited has entered into a long-term manufacturing and supply agreement with a leading global pharmaceuticals company to manufacture and supply advanced intermediates that...
The National Accreditation Board for Hospitals and Healthcare Providers (NABH) has restated its zero-tolerance policy
Steriline, a company highly specialised in the production of complete aseptic packaging lines for injectables and ophthalmic products for global pharmaceutical companies, will participate...
Meril Life Sciences today announced one-year results from its pivotal LANDMARK trial, presented during the prestigious Late-Breaking Trial session at EuroPCR 2025, one of the world’s premier cardiology conferences held annually in Paris, France.
Lupin pharmaceutical announced that it has entered into a license and supply agreement with SteinCares for the commercialization of biosimilar ranibizumab throughout all of Latin America...
In the developing side of drug development for mood and anxiety disorders, Syngene has stressed the critical need to precisely measure
After a close inspection of its active pharmaceutical ingredient (API) manufacturing unit, Dr. Reddy’s Laboratories has received a Form 483 with two observations from the US Food and Drug Administration (USFDA)...
Astellas Pharma and Pfizer have reported new updated long-term results from the open-label extension portion of the Phase 3 ARCHES study that utilized a five-year follow-up to demonstrate continued overall survival (OS) benefits...